Cargando…

Multi-factor combined biomarker screening strategy to rapidly diagnose Alzheimer's disease and evaluate drug effect based on a rat model

Alzheimer's disease (AD) represents the main form of dementia; however, valid diagnosis and treatment measures are lacking. The discovery of valuable biomarkers through omics technologies can help solve this problem. For this reason, metabolomic analysis using ultra-performance liquid chromatog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yanmeng, Zhang, Xinyue, Lin, Weiwei, Kehriman, Nurmuhammat, Kuang, Wen, Ling, Xiaomei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Xi'an Jiaotong University 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463486/ https://www.ncbi.nlm.nih.gov/pubmed/36105160 http://dx.doi.org/10.1016/j.jpha.2022.04.003

Ejemplares similares

Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
por: Liu, Yi, et al.
Publicado: (2023)

Utility of a shortened Hasegawa Dementia Scale Revised questionnaire to rapidly screen and diagnose Alzheimer’s disease
por: Gong, Qian, et al.
Publicado: (2021)

The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer’s Disease
por: Nance, Christin, et al.
Publicado: (2019)

A rapid screening classifier for diagnosing COVID-19
por: Xia, Yang, et al.
Publicado: (2021)

Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
por: Gong, Cheng-Xin, et al.
Publicado: (2022)

Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
por: Park, Jung Eun, et al.
Publicado: (2021)

Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia
por: Oshikubo, Gaku, et al.
Publicado: (2020)

Rapid Estimation of Soil Pb Concentration Based on Spectral Feature Screening and Multi-Strategy Spectral Fusion
por: Zhang, Zhenlong, et al.
Publicado: (2023)

Screening of Serum Biomarkers of Coal Workers’ Pneumoconiosis by Metabolomics Combined with Machine Learning Strategy
por: Chen, Zhangjian, et al.
Publicado: (2022)

Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson
por: Wolgin, Michael, et al.
Publicado: (2022)

Combined Multi-Atlas and Multi-Layer Perception for Alzheimer's Disease Classification
por: Hong, Xin, et al.
Publicado: (2022)

Accuracy of the Brief Cognitive Screening Battery for diagnosing Alzheimer's disease defined by cerebrospinal fluid biomarkers and AT(N) classification: a case-control study
por: Peles, Patrícia Regina Henrique, et al.
Publicado: (2021)

Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs
por: Espargaró, Alba, et al.
Publicado: (2016)

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease
por: Öhrfelt, Annika, et al.
Publicado: (2011)

Alzheimer's disease biomarkers: another tool for FAA pilot screening?
por: Lawrence, Matthew W, et al.
Publicado: (2019)

Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
por: Coles, Madilyn, et al.
Publicado: (2022)

Dendrimers in Alzheimer’s Disease: Recent Approaches in Multi-Targeting Strategies
por: Arbez-Gindre, Cécile, et al.
Publicado: (2023)

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease
por: Herden, Janne Marieke, et al.
Publicado: (2023)

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports
por: Slats, Diane, et al.
Publicado: (2010)

Diagnosing Alzheimer’s disease: are we any nearer to useful biomarker-based, non-invasive tests?
por: Fletcher, Lydia C. B., et al.
Publicado: (2013)

The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications
por: Gossye, Helena, et al.
Publicado: (2019)

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer’s disease
por: Herden, Janne Marieke, et al.
Publicado: (2023)

Rapid Screening of Novel Agents for Combination Therapy in Sarcomas
por: Cubitt, Christopher L., et al.
Publicado: (2013)

An effective docking strategy for virtual screening based on multi-objective optimization algorithm
por: Li, Honglin, et al.
Publicado: (2009)

Systematic Search for Novel Circulating Biomarkers Associated with Extracellular Vesicles in Alzheimer’s Disease: Combining Literature Screening and Database Mining Approaches
por: Vogrinc, David, et al.
Publicado: (2021)

Screening strategies to identify HSP70 modulators to treat Alzheimer’s disease
por: Repalli, Jayanthi, et al.
Publicado: (2015)

Rapid Antigen Test Combine with Nucleic Acid Detection: A Better Strategy for COVID-19 Screening at Points of Entry
por: Zhan, Zhiqing, et al.
Publicado: (2022)

Anti-Inflammatory, Immunomodulatory, and Heme Oxygenase-1 Inhibitory Activities of Ravan Napas, a Formulation of Uighur Traditional Medicine, in a Rat Model of Allergic Asthma
por: Abdureyim, Sajida, et al.
Publicado: (2011)

Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with “screen, diagnose and treat” using innovative tools and strategies
por: Ndung’u, Joseph Mathu, et al.
Publicado: (2020)

Combined Biomarker and Computed Tomography Screening Strategies for Lung Cancer: Projections of Health and Economic Tradeoffs in the US Population
por: Kong, Chung Yin, et al.
Publicado: (2016)

Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease
por: François, Maxime, et al.
Publicado: (2022)

Diagnosed Mild Cognitive Impairment Due to Alzheimer’s Disease with PET Biomarkers of Beta Amyloid and Neuronal Dysfunction
por: Hatashita, Shizuo, et al.
Publicado: (2013)

Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease
por: Tsai, Andrew, et al.
Publicado: (2014)

Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer’s Disease Biomarker and Mild Cognitive Impairment Diagnoses
por: Nation, Daniel A., et al.
Publicado: (2019)

Diagnosing Dengue at the Point-of-Care: Utility of a Rapid Combined Diagnostic Kit in Singapore
por: Gan, Victor C., et al.
Publicado: (2014)

Multi-component gene network design as a survival strategy in diverse environments
por: Luo, Xinyue, et al.
Publicado: (2018)

Aqueous extract of dioscorea opposita thunb. normalizes the hypertension in 2K1C hypertensive rats
por: Amat, Nurmuhammat, et al.
Publicado: (2014)

Alzheimer's Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field
por: Valenti, Denise A.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_alukdmle3jmhuo7d09qtsh0ur8